#news #biotech After seeing its GSK-backed trial ditched, LAG-3-focused Immutep secures cash, plots new trial push

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: After seeing its GSK-backed trial ditched, LAG-3-focused Immutep secures cash, plots new trial push .After seeing its GSK-backed trial ditched, LAG-3-focused Immutep secures cash, plots new trial push
badams
Mon, 06/21/2021 – 04:49

from FierceBiotech: Biotech https://ift.tt/2SfO56t